COSTS ANALYSIS OF PCR UNYVEROTM I60-ITI TECHNIQUE FOR DETECTING MICROORGANISMS IN PATIENTS WITH SUSPECTED CHRONIC INFECTION AT MUSCULOSKELETAL IMPLANTS

Author(s)

Torres C1, Oyagüez I1, Prieto L2, Rodriguez G2, Esteban J2
1Pharmacoeconomics & Outcomes Research Iberia, Madrid, Spain, 2IIS- Fundación Jiménez Díaz., Madrid, Spain

OBJECTIVES:   Polymerase chain reaction (PCR) techniques could provide an earlier diagnosis than traditional techniques (TT) to identify chronic infections in patients with musculoskeletal implants. The aim was to determine costs associated to microorganism’s diagnosis in sonicate samples of musculoskeletal implants, comparing the addition of a PCR technique (UnyveroTM i60-ITI) to TT versus TT only. METHODS: A preliminary cost analysis was developed to estimate the hospital costs in patients admitted at Fundación Jimenez Diaz Hospital (May-2014 to April-2015) for musculoskeletal implant removal due to chronic infection suspect. Sonicated samples were tested for microbiological diagnosis using TT. Additionally, samples were tested using UnyveroTM i60-ITI. Medical hospitals records were reviewed for data collection: sociodemographic data; type, dosing and antibiotic treatments; and hospital length of stay (LOS). Intravenous vancomycin and ceftazidime were selected as the initial empiric treatment. Replacement to a specific antibiotic was performed after microbiological diagnosis. Total estimated costs (€, 2015) included antibiotic treatment, hospital stay (€1,006 per day) and UnyveroTM i60-ITI kits (€350 per kit) costs. RESULTS: Ten patients were retrieved for preliminary analysis (average age: 75.39±6.31 years; 20% men). Hip (40%) and knee (40%) were the most frequent implant sites. Average period from implant removal to final diagnosis lasted 4.60±1.35 days with TT. UnyveroTM i60-ITI diagnosis was available 24h after removal. LOS was 24.4 days for TT and 23.3 days for UnyveroTM i60-ITI added to TT. The average antibiotic treatment cost was €1,016.01 for TT and €976.84 for UnyveroTM i60-ITI added to TT. Hospital stay cost was €25,591.26 for TT and €24,361.98 for UnyveroTM i60-ITI added to TT. The use of UnyveroTM i60-ITI reduced average total costs in €840.67. CONCLUSIONS: UnyveroTM i60-ITI PCR for microbiological identification in musculoskeletal implants sonicated is associated to faster diagnosis and shorter hospital stays than traditional techniques only, allowing cost savings at hospital level.

Conference/Value in Health Info

2015-11, ISPOR Europe 2015, Milan, Italy

Value in Health, Vol. 18, No. 7 (November 2015)

Code

PMD41

Topic

Economic Evaluation

Topic Subcategory

Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

Infectious Disease (non-vaccine)

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×